Abbott Laboratories (NYSE:ABT)

132.43
Delayed Data
As of Dec 07
 -0.04 / -0.03%
Today’s Change
105.32
Today|||52-Week Range
134.08
+20.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line563.0M654.0M672.0M1.0B
 
 
 
 
 
Depreciation813.0M763.0M753.0M751.0M
 
 
 
 
 
Total Other Cash Flow83.0M374.0M226.0M114.0M
 
 
 
 
 
Funds From Operations1.5B1.8B1.7B1.9B
 
 
 
 
 
Funds From/For Other Operating Expenses-724.0M26.0M939.0M811.0M
 
 
 
 
 
Net Cash Flow - Operating Activities2.2B1.8B712.0M1.1B
 
 
 
 
 
 
InvestingIncrease In Investments19.0M-108.0M----
 
 
 
Decrease In Investments0.0073.0M2.0M0.00
 
 
 
Capital Expenditures-354.0M-467.0M-335.0M-468.0M
 
 
 
 
 
Fixed Asset Disposal0.000.00--48.0M
 
 
Net Assets From Acquisitions 0.000.00-78.0M-82.0M
 
 
 
Other Investing - Sources12.0M6.0M15.0M4.0M
 
 
 
 
 
Net Cash Flow Investing-323.0M-496.0M-396.0M-498.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-118.0M-48.0M13.0M27.0M
 
 
 
 
 
Long Term Borrowings4.0B-2.0M0.000.00
 
 
 
Long Term Debt Reduction-999.0M-4.2B-500.0M-21.0M
 
 
 
 
 
Net Proceeds Stock Sale74.0M27.0M127.0M117.0M
 
 
 
 
 
Common Preferred Redeemed-3.0M-104.0M-217.0M-4.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-494.0M-495.0M-565.0M-568.0M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing2.5B-4.8B-1.1B-449.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-27.0M-18.0M4.0M2.0M
 
 
 
 
 
 
Net Change In Cash4.3B-3.5B-826.0M113.0M